Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response
Status: Enrolling
Updated:  8/7/2012
University of Wisconsin
1616
mi
from 98109
Madison, WI
An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response
Status: Enrolling
Updated: 8/7/2012
University of Wisconsin
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Wishard Hospital - Indiana University School of Medicine
1868
mi
from 98109
Indianapolis, IN
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Wishard Hospital - Indiana University School of Medicine
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Louisiana State University
2099
mi
from 98109
New Orleans, LA
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Louisiana State University
2099
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
New England Center for Clinical Research
2502
mi
from 98109
Fall River, MA
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
New England Center for Clinical Research
2502
mi
from 98109
Fall River, MA
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Geneuity Clinical Research Services
2116
mi
from 98109
Maryville, TN
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Geneuity Clinical Research Services
2116
mi
from 98109
Maryville, TN
Click here to add this to my saved trials
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated:  8/10/2012
Planned Parenthood Gulf Coast
1890
mi
from 98109
Houston, TX
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Prospective Collection of Female First-catch Urine, Vaginal Swab, Endocervical Swab, and Cervical Specimens for Testing With the APTIMA Trichomonas Vaginalis Assay
Status: Enrolling
Updated: 8/10/2012
Planned Parenthood Gulf Coast
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated:  8/12/2012
Centering Pregnancy and Parenting Association
2427
mi
from 98109
Cheshire, CT
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated: 8/12/2012
Centering Pregnancy and Parenting Association
2427
mi
from 98109
Cheshire, CT
Click here to add this to my saved trials
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated:  8/12/2012
Yale University Connecticut Women's Health Project
2432
mi
from 98109
New Haven, CT
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated: 8/12/2012
Yale University Connecticut Women's Health Project
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated:  8/12/2012
Clinical Directors Network
2401
mi
from 98109
New York, NY
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study
Status: Enrolling
Updated: 8/12/2012
Clinical Directors Network
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1049
mi
from 98109
La Jolla, CA
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1049
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1021
mi
from 98109
Denver, CO
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1021
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
2366
mi
from 98109
Newark, DE
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
2366
mi
from 98109
Newark, DE
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1737
mi
from 98109
Chicago, IL
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1500
mi
from 98109
Kansas City, KA
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1500
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
2458
mi
from 98109
Stony Brook, NY
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
2458
mi
from 98109
Stony Brook, NY
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated:  8/15/2012
Clinical Research Facility
1892
mi
from 98109
Houston, TX
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520 AM3)
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1b; Protocol No. P05520)
Status: Enrolling
Updated: 8/15/2012
Clinical Research Facility
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Status: Enrolling
Updated:  8/20/2012
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
Status: Enrolling
Updated: 8/20/2012
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  8/20/2012
West Virginia University Hospitals Inc.
2160
mi
from 98109
Morgantown, WV
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 8/20/2012
West Virginia University Hospitals Inc.
2160
mi
from 98109
Morgantown, WV
Click here to add this to my saved trials
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated:  8/21/2012
Sentara Norfolk General Hospital
2429
mi
from 98109
Norfolk, VA
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated: 8/21/2012
Sentara Norfolk General Hospital
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Concentrics Center for Research
1865
mi
from 98109
Indianapolis, IN
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Concentrics Center for Research
1865
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Cyn3rgy Research
146
mi
from 98109
Gresham, OR
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Cyn3rgy Research
146
mi
from 98109
Gresham, OR
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
DMI Research
2519
mi
from 98109
Pinellas, FL
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
DMI Research
2519
mi
from 98109
Pinellas, FL
Click here to add this to my saved trials
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated:  8/21/2012
Clinical Research Associates Incorporated
1971
mi
from 98109
Nashville, TN
Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
Status: Enrolling
Updated: 8/21/2012
Clinical Research Associates Incorporated
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
An Open Label, Non-Randomized, Single Dose, Two Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
Status: Enrolling
Updated:  8/23/2012
GSK Investigational Site
1450
mi
from 98109
Rochester, MN
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
An Open Label, Non-Randomized, Single Dose, Two Period, Cross-Over, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
Status: Enrolling
Updated: 8/23/2012
GSK Investigational Site
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.
Status: Enrolling
Updated:  9/18/2012
University of Texas Health Science Center at Tyler
1764
mi
from 98109
Tyler, TX
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Dose Comparison Study of Tuberculin Purified Protein Derivative (PPD)With Standard Tuberculin Purified Protein Derivative.
Status: Enrolling
Updated: 9/18/2012
University of Texas Health Science Center at Tyler
1764
mi
from 98109
Tyler, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
University of Kentucky Chandler Medical Center
2005
mi
from 98109
Lexington, KY
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
University of Kentucky Chandler Medical Center
2005
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
LSU Health Sciences Center
1820
mi
from 98109
Shreveport, LA
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
LSU Health Sciences Center
1820
mi
from 98109
Shreveport, LA
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
University of Mississippi Medical Center
1872
mi
from 98109
Jackson, MI
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
University of Mississippi Medical Center
1872
mi
from 98109
Jackson, MI
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Washington University
1717
mi
from 98109
St. Louis, MO
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Washington University
1717
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Duke Medical Center
2339
mi
from 98109
Durham, NC
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Duke Medical Center
2339
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Vidant Health
2427
mi
from 98109
Greenville, NC
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Vidant Health
2427
mi
from 98109
Greenville, NC
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
St. Joseph Regional Health Center
1805
mi
from 98109
Bryan, TX
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
St. Joseph Regional Health Center
1805
mi
from 98109
Bryan, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Harris Methodist Hospital
1660
mi
from 98109
Ft. Worth, TX
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Harris Methodist Hospital
1660
mi
from 98109
Ft. Worth, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Scott & White Hospital
1740
mi
from 98109
Temple, TX
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Scott & White Hospital
1740
mi
from 98109
Temple, TX
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
University of Virginia, Blue Ridge PC
2285
mi
from 98109
Charlottesville, VA
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
University of Virginia, Blue Ridge PC
2285
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated:  9/19/2012
Virginia Commonwealth University Richmond
2351
mi
from 98109
Richmond, VA
Copperhead Envenomation Observational Study
Observational Study of Recovery From Copperhead Snake Envenomation
Status: Enrolling
Updated: 9/19/2012
Virginia Commonwealth University Richmond
2351
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Indiana University School of Medicine
1867
mi
from 98109
Indianapolis, IN
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Indiana University School of Medicine
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
University of Kentucky Medical Center
2005
mi
from 98109
Lexington, KY
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
University of Kentucky Medical Center
2005
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Washington University School of Medicine
1718
mi
from 98109
St.Louis, MO
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Washington University School of Medicine
1718
mi
from 98109
St.Louis, MO
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated:  9/27/2012
Vanderbilt AIDS Clinical Trials Center
1970
mi
from 98109
Nashville, TN
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination
Status: Enrolling
Updated: 9/27/2012
Vanderbilt AIDS Clinical Trials Center
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated:  10/1/2012
Centers for Disease Control and Prevention
2187
mi
from 98109
Atlanta, GA
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated: 10/1/2012
Centers for Disease Control and Prevention
2187
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated:  10/1/2012
BOTUSA HIV Prevention Research Unit
mi
from 98109
Francistown and Gaborone,
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana
Status: Enrolling
Updated: 10/1/2012
BOTUSA HIV Prevention Research Unit
mi
from 98109
Francistown and Gaborone,
Click here to add this to my saved trials
Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis
Evaluation of Sulfobutylether-ß-cyclodextrin Sodium (SBECD) Accumulation and Voriconazole Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Status: Enrolling
Updated:  10/1/2012
University of Colorado Hospital
1023
mi
from 98109
Denver, CO
Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis
Evaluation of Sulfobutylether-ß-cyclodextrin Sodium (SBECD) Accumulation and Voriconazole Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Status: Enrolling
Updated: 10/1/2012
University of Colorado Hospital
1023
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 in Healthy Adult Subjects
Status: Enrolling
Updated:  10/4/2012
Celerion
1125
mi
from 98109
Tempe, AZ
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 in Healthy Adult Subjects
Status: Enrolling
Updated: 10/4/2012
Celerion
1125
mi
from 98109
Tempe, AZ
Click here to add this to my saved trials